Our Approach

 
Davis Polk represents a number of clients in complex (including multidistrict) consumer class action litigations in federal and state courts across the country.

Notable Matters

  • We represented Pfizer in numerous consumer fraud class actions, including federal multidistrict litigation (MDL), relating to the marketing of Neurontin. We defeated class certification in the MDL and in state courts and have won dismissal of a number of other purported class actions brought on behalf of national and state-wide classes of consumers and third-party payers.


  • We won a significant victory on behalf of Verizon in New York state court that resulted in the class being decertified in a series of purported consumer class actions alleging that Verizon had falsely advertised and marketed its high-speed Internet service.


  • We have represented AstraZeneca in recent major consumer class actions, including:
    • Obtaining a dismissal for AstraZeneca of a federal multidistrict class action in New York relating to claims that settlement of patent litigation over the cancer drug tamoxifen violated antitrust and consumer protection laws.
    • Lawsuits over pharmaceutical pricing, including a multidistrict litigation that settled after trial and numerous state-court actions brought by state attorneys general.
    • Numerous cases in which private insurers, consumers, states and state agencies have asserted various common law and consumer protection claims in federal and state courts relating to allegedly inflated reimbursements for prescription drugs by Medicare, Medicaid and private insurers. These actions have involved extensive pretrial proceedings, trials and appeals.
More >